Publications by authors named "Assen Dudov"

Claim this Profile
R
Real-world evidence of first-line osimertinib effectiveness in Bulgarian patients: a retrospective analysis.
Manoela Manova, Boryana Ivanova, Jeliazko Arabadjiev, Radoslav Mangaldzhiev, Assen Dudov

Expert Rev Pharmacoecon Outcomes Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bulgarian exploratory analysis of time from diagnosis to treatment of lung cancer patients (Beat) - a retrospective database study on the patient pathway and time from diagnosis to treatment.
Assen Dudov, Nikolay Conev, Mila Petrova, Ivan Tonev, Martina Nacheva

BMC Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late Ga PSMA-positive Pancreatic Metastasis From Renal Cell Carcinoma in a Patient with Metastatic Prostate Cancer: A Mission Impossible.
Gabriela Mateva, Nikolina Novoselska, Assen Dudov, Marina Garcheva-Tsacheva, Pavel Bochev

Mol Imaging Radionucl Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma.
David I Quinn, John Nemunaitis, Jyotsna Fuloria, Carolyn D Britten, Nashat Gabrail, Assen Dudov

Clin Pharmacokinet· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis